Results 11 to 20 of about 5,004,732 (313)

Gaze holding in healthy subjects. [PDF]

open access: yesPLoS ONE, 2013
Eccentric gaze in darkness evokes minor centripetal eye drifts in healthy subjects, as cerebellar control sufficiently compensates for the inherent deficiencies of the brainstem gaze-holding network.
Giovanni Bertolini   +7 more
doaj   +5 more sources

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects

open access: yesAntibiotics, 2023
This study aimed to explore the pharmacokinetics (PK) and safety of oral (PO) and intravenous (IV) lefamulin in healthy Chinese subjects and to evaluate the efficacy of the intravenous administration regimen using pharmacokinetic/pharmacodynamic (PK/PD ...
Yingying Hu   +9 more
doaj   +1 more source

High-Fat Breakfast Increases Bioavailability of Albendazole Compared to Low-Fat Breakfast: Single-Dose Study in Healthy Subjects

open access: yesFrontiers in Pharmacology, 2021
Purpose: Albendazole is a benzimidazole carbamate drug with anthelmintic and antiprotozoal activity against intestinal and tissue parasites. It has been described that the administration with meals increases albendazole absorption. Our aim was to compare
Dolores Ochoa   +12 more
doaj   +1 more source

Serum apolipoprotein B increased among tuberculosis patients compared to healthy subjects

open access: yesUniversa Medicina, 2021
Background The burden of tuberculosis (TB) and cardiovascular disease (CVD) is enormous worldwide. Public health programs have been challenged with the overlapping of TB and CVD epidemics.Mycobacterium tuberculosis (MTB) is also a main driver of ...
Augustine Chinedu Ihim   +4 more
doaj   +1 more source

Tadalafil pharmacokinetics in healthy subjects [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2005
AimsTo characterize tadalafil plasma pharmacokinetics in healthy subjects following single and multiple doses.MethodsNoncompartmental parameters were calculated for healthy subjects receiving a single 2.5–20‐mg tadalafil dose in 13 clinical pharmacology studies.
S Thomas, Forgue   +6 more
openaire   +2 more sources

Pharmacokinetics, pharmacodynamics, and safety of prandial oral insulin (N11005) in healthy subjects

open access: yesFrontiers in Endocrinology, 2023
AimsTo verify whether the oral insulin N11005 is administered as a prandial insulin by assessing the pharmacokinetics (PK), pharmacodynamics (PD), and safety profiles of N11005 with a short-acting biosynthetic human insulin (Novolin R) as reference ...
Qi Pan   +14 more
doaj   +1 more source

The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

open access: yesFrontiers in Psychiatry, 2021
Background: Cannabis is known to have a broad range of effects on behavior, including experiencing a “high” and tranquility/relaxation. However, there are several adverse behavioral sequalae that can arise from cannabis use, depending on frequency of use,
Maryam Sorkhou   +5 more
doaj   +1 more source

Evaluation of Platelet Count, Anti-microbial Efficacy, and Fibrin Network Pattern for Advanced Platelet Rich Fibrin versus Titanium Platelet Rich Fibrin Prepared from Blood Samples of Young Adults: An Ex-vivo Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Platelet concentrates have gained popularity in periodontal regenerative therapy owing to their autologous nature. Platelet Rich Fibrin (PRF) can be classified into various types based on the centrifugation protocol.
Bhavya Chadarajupalli   +5 more
doaj   +1 more source

An open label, single arm, prospective clinical study to evaluate liver safety and tolerability of PUREMERIC™ (standardized extract from Curcuma longa) in healthy subjects

open access: yesToxicology Reports, 2021
Objective: Turmeric is a culinary spice valued since ancient time for its medicinal properties, mostly attributed to curcumin, the major polyphenol present. The safety of curcumin is well established in humans.
Sudeep HV   +3 more
doaj   +1 more source

Pharmacokinetics of bambuterol in healthy subjects [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 1998
Aims To study the pharmacokinetics and bioavailability of the prodrug bambuterol and its bronchodilator moiety terbutaline in healthy subjects. Methods Eight healthy subjects (four women) received intravenous doses of bambuterol and terbutaline. On a third occasion, they, plus another four subjects, ingested oral bambuterol as a single dose followed ...
L, Nyberg   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy